| Name | Title | Contact Details |
|---|
Dynalloy Industries Inc is a College Station, TX-based company in the Manufacturing sector.
AeroGrow International, Inc. is one of the leading companies in the Manufacturing sector.
Norwell Lighting & Accessories is a East Taunton, MA-based company in the Manufacturing sector.
Lumense, located in Atlanta`s Advanced Technology Development Center (ATDC) next to the Georgia Tech campus, offers real-time, in situ, chemical and biological sensors for use in a broad range of applications, including those in the water, food and beverage, and agriculture sectors. Lumense developed SensorIT, a common, scalable sensor platform augmented with low cost optical detectors customized for specific targets, allowing customers to move from a reactive to a proactive approach to contaminant management and recipe control. The SensorIT platform has been used to continuously detect trace amounts of dozens of different substances, many of which previously could only be detected and quantified with expensive laboratory equipment after sampling. An ammonia monitor for air monitoring in poultry houses is the first product to be released under Lumense`s SensorIT technology platform. As part of the platform, customers will be able to view and manage their sensor data remotely and securely. Products under development include a sensor for detecting trace levels of impurities in gases used by the food and beverage industry, and a sensor for monitoring water quality.
Neos Therapeutics is focused on developing, manufacturing and commercializing branded products utilizing our proprietary extended-release drug delivery technology platform, which serves as the basis for our three product candidates being investigated for the treatment of attention deficit hyperactivity disorder (ADHD). Our ADHD product candidates include the following formulations; oral disintegrating tablets (ODT) and liquid suspension. Drug Delivery Platform: Our proprietary extended-release drug delivery platform has enabled us to create new patient- and caregiver-friendly dosage forms of methylphenidate and amphetamine. Formulations: In 2014 alone, 63.1 million prescriptions for medications with ADHD labeling, and principally in extended-release formulations, were written in the United States. The majority of currently available dosage forms for ADHD are tablets and capsules. The two lead Neos Therapeutics product candidates provide a plasma concentration-time profile that is consistent with once daily dosing in an orally disintegrating tablet that disintegrates in the mouth without water. Our goal is to be a leading pharmaceutical company focused on the development, manufacture and commercialization of branded pharmaceutical products that utilize our proprietary extended-release drug delivery technology platform. Neos Therapeutics is a growing, dynamic company that can provide employees with the opportunities and challenges they need to enjoy a rewarding career and make a difference in the lives of others. Our success depends on a motivated team of people collaborating to create quality healthcare products. This requires employees with exceptional leadership skills, flexibility, technical expertise and a commitment to excellence. We offer competitive compensation packages to full-time employees. We seek to attract the right people and provide incentives and career development that can turn employment into opportunity.